3-hydroxybutyric acid has been researched along with Muscle Weakness in 3 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Muscle weakness is a complication of critical illness which hampers recovery." | 1.62 | Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate. ( Derde, S; Derese, I; Ghesquière, B; Goossens, C; Langouche, L; Van den Berghe, G; Van Veldhoven, PP; Vander Perre, S; Weckx, R, 2021) |
| "The 'obesity paradox' of critical illness refers to better survival with a higher body mass index." | 1.46 | Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness. ( De Bock, K; Derde, S; Dufour, T; Goossens, C; Güiza, F; Hermans, G; Janssens, T; Langouche, L; Marques, MB; Thiessen, SE; Van den Berghe, G; Vander Perre, S; Vanhorebeek, I, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Weckx, R | 2 |
| Goossens, C | 3 |
| Derde, S | 3 |
| Pauwels, L | 1 |
| Vander Perre, S | 3 |
| Van den Bergh, G | 1 |
| Langouche, L | 3 |
| Derese, I | 1 |
| Van Veldhoven, PP | 1 |
| Ghesquière, B | 1 |
| Van den Berghe, G | 2 |
| Marques, MB | 1 |
| Dufour, T | 1 |
| Thiessen, SE | 1 |
| Güiza, F | 1 |
| Janssens, T | 1 |
| Hermans, G | 1 |
| Vanhorebeek, I | 1 |
| De Bock, K | 1 |
3 other studies available for 3-hydroxybutyric acid and Muscle Weakness
| Article | Year |
|---|---|
Identification of the toxic threshold of 3-hydroxybutyrate-sodium supplementation in septic mice.
Topics: 3-Hydroxybutyric Acid; Acid-Base Equilibrium; Aldosterone; Animals; Brain; Dietary Supplements; Dose | 2021 |
Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate.
Topics: 3-Hydroxybutyric Acid; Aged; Aged, 80 and over; Animals; Cholesterol; Critical Illness; Disease Mode | 2021 |
Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness.
Topics: 3-Hydroxybutyric Acid; Aged; Animals; Body Composition; Critical Illness; Fasting; Fatty Acids; Fema | 2017 |